Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2024, 5(1); doi: 10.25236/AJMHS.2024.050112.

A Current Clinical Overview of Atrophic Gastritis

Author(s)

Lingyan Chen1, Mengmeng Ye1, Chunyan Liu1, Chengyan Ma1, Tao Yu2

Corresponding Author:
Tao Yu
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

2Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710003, China

Abstract

Chronic atrophic gastritis(CAG), as a subtype of chronic gastritis, refers to the loss of gastric gland function in the inflammatory background caused by Helicobacter pylori (H.pylori) infection or autoimmune factors, with or without intestinal metaplasia(IM) , and is a precancerous disease. The main clinical manifestations of CAG are upper abdominal distension, early satiety, belching, decreased appetite, and irregular dull pain in the upper abdomen. As a clinically common and refractory disease, CAG can go on a long time. Traditional Chinese and western medicine in CAG are cut both ways, and this article provides a detailed description of the research progress on CAG to and provide some reference for clinic.

Keywords

Chronic atrophic gastritis; H. pylori; Diagnostics; Treatment; TCM

Cite This Paper

Lingyan Chen, Mengmeng Ye, Chunyan Liu, Chengyan Ma, Tao Yu. A Current Clinical Overview of Atrophic Gastritis. Academic Journal of Medicine & Health Sciences (2024), Vol. 5, Issue 1: 76-81. https://doi.org/10.25236/AJMHS.2024.050112.

References

[1] Shah Shailja C, Piazuelo M Blanca, Kuipers Ernst J, et al. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review [J]. Gastroenterology, 2021, 161(4):1325-1332.e7. 

[2] Correa P. A human model of gastric carcinogenesis [J]. Cancer research, 1988, 48(13):3554-3560.

[3] Vannella Lucy, Lahner Edith, Annibale Bruno, et al. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal [J]. World journal of gastroenterology, 2012, 18 (12):1279-1285.

[4] Wang Yajie, Guo Song, Yang Yang, et al. Epidemiological and risk factor analysis of chronic atrophic gastritis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2019, 27(11):874-878.

[5] Du Yiqi, Bai Yu, Xie Pei, et al. Chronic gastritis in China: a national multi-center survey [J]. BMC gastroenterology, 2014, 14(1):21.

[6] Wang Nuanfeng, Chu Haikun, Huang Shumin, et al. Clinical characteristics of chronic atrophic gastritis patients in Heilongjiang province [J]. Chinese Journal of Public Health, 2017, 33(7):1109-1111.

[7] Sipponen Pentti, Maaroos Heidi-Ingrid. Chronic gastritis [J]. Scandinavian journal of gastroenterology, 2015, 50(6):657-667.

[8] Leja Mārcis, Grinberga-Derica Ieva, Bilgilier Ceren, et al. Review: Epidemiology of Helicobacter pylori infection [J]. Helicobacter, 2019, 241(1):e12635.

[9] Burucoa Christophe, Axon Anthony. Epidemiology of Helicobacter pylori infection [J]. Helicobacter, 2017, 221. 

[10] Camilo Vania, Sugiyama Toshiro, Touati Eliette, et al. Pathogenesis of Helicobacter pylori infection. [J]. Helicobacter, 2017, 221.

[11] Waskito Langgeng Agung, Salama Nina R, Yamaoka Yoshio, et al. Pathogenesis of Helicobacter pylori infection [J]. Helicobacter, 2018, 231:e12516.

[12] Shamshul Ansari, Yoshio Yamaoka. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity [J]. Toxins, 2019, 11(11):677-677.

[13] Skander Hathroubi, Stephanie L. Servetas, Ian Windham, et al. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis [J]. Microbiol. Mol. Biol. Rev., 2018, 82(2):e00001-e00018.

[14] Annibale Bruno, Esposito Gianluca, Lahner Edith, et al. A current clinical overview of atrophic gastritis [J]. Expert review of gastroenterology & hepatology, 2020, 14(2):93-102.

[15] Cheng Shuping, Zhang Qingyu, Li Ming, et al. Progress in diagnosis and treatment of chronic autoimmune atrophic gastritis [J]. Chinese Journal of Gastroenterology and Hepatology, 2021, 30(8): 940-945.

[16] Fu Yangxi, Han Xu, Liang Shuo, et al. Advances in the pathogenesis of chronic atrophic gastritis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2023, 31(6):479-484.

[17] Yang Hong, Hou Jiayu. Experimental Study on Chronic Atrophic Gastritis Induced by Bile Reflux [J]. Journal of Beijing University of Traditional Chinese Medicine, 2001, 24(5):26-29.

[18] Matsuhisa Takeshi, Arakawa Tetsuo, Watanabe Tetsuo, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. [J]. Digestive endoscopy: official journal of the Japan Gastroenterological Endoscopy Society, 2013, 25(5):519-525.

[19] Su Baowei, Lin Qiang, Wang Jingjie. Relationship between bile reflux gastritis and intestinal metaplasia and related molecular mechanism [J]. Journal of Shanxi Medical University, 2021, 52(3): 344-349.

[20] Dong Tianyi, Lan Xiang, Fan Bingbing, et al. Gastric bacteria as potential biomarkers for the diagnosis of atrophic gastritis [J]. Molecular biology reports, 2022, 50(1):655-664.

[21] Sung Joseph J Y, Coker Olabisi Oluwabukola, Chu Eagle, et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication [J]. Gut, 2020, 69(9):1572-1580.

[22] Li Junxiang, Chen Jing, Lv Bin, et al. Consensus on the Diagnosis and Treatment of Chronic Atrophic Gastritis with Integrated Traditional Chinese and Western Medicine (2017) [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2018, 26(2):121-131.

[23] Redéen S, Petersson F, Jönsson K-A, et al. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample [J]. Endoscopy, 2003, 35(11):946-950.

[24] Zagari R M, Rabitti S, Greenwood D C, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis [J]. Alimentary pharmacology & therapeutics, 2017, 46(7):657-667.

[25] Zhang Xuezhi, Wei Wei, Lan Yu. Chinese Medicine and Western Medicine Collaborative Expert Consensus on Diagnosis and Treatment of Helicobacter Pylori Caused Gastritis in Adults(2020,Beijing) [J]. Journal of Traditional Chinese Medicine, 2020, 61(22):2016-2024.

[26] Liu Wenzhong, Xie Yong, Lu Hong, et al. Fifth National Consensus Report on the Management of Helicobacter pylori Infection [J]. Chinese Journal of Gastroenterology, 2017, 22(6):346-360.

[27] Zhang Xin, Hu Dongqing, Zhou Xiaofeng, et al. Progress in diagnosis and treatment of chronic atrophic gastritis with depression and anxiety [J]. Shanxi Journal of Traditional Chinese Medicine, 2017, 33(12):55-57.

[28] Ge Wensong, Liu Jiemin, An Zhenxiang, et al. Exploration of Traditional Chinese Medicine in Reversing the Pathological Changes of Chronic Atrophic Gastritis [J]. Sichuan Journal of Traditional Chinese Medicine, 2004, 22(1):19-20.

[29] Yang Liangjun, Cai Tiantian, Li Jiali, et al. Systems Pharmacology Uncovers Multiple Mechanisms of Sijunzi Decoction for Treatment of Chronic Atrophic Gastritis [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(9):1803-1806+2013.

[30] Xu Aili, Tang Bin, Wang Yuan, et al. Mechanism ofBanxia Xiexin Decoction in treating chronic atrophic gastritis by integrated pharmacology [J]. Beijing Journal of Traditional Chinese Medicine, 2019, 0(5):407-412.

[31] Zhou Wuai, Zhang Huan, Wang Xin, et al. Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis [J]. Phytomedicine, 2022, 95:153837-153837. 

[32] Ji Xu, Liu Lu, Du Xin, et al. Therapeutic Effect of Fast Needling of Fire Acupuncture Combined with Needle-Warming Moxibustion on CAG with Cold-Deficiency of Spleen and Stomach and Its Influence to Serum Levels of G17,PGI and PGR [J]. Journal of Clinical Acupuncture and Moxibustion, 2022, 38(4):32-36.